Angiopep-2 Modified Exosomes Load Rifampicin with Potential for Treating Central Nervous System Tuberculosis.

Han LiYinan DingJiayan HuangYanyan ZhaoWei ChenQiusha TangYanli AnRong Chen Chun-Mei Hu

Published in: International journal of nanomedicine (2023)

In summary, excellent targeting ability, high antitubercular activity and biocompatibility endow ANG-Exo-RIF with potential for use in future translation-aimed research and provide hope for an effective CNS-TB treatment.

Keyphrases

mycobacterium tuberculosis
pulmonary tuberculosis
mesenchymal stem cells
stem cells
human health
angiotensin ii
emergency department
risk assessment
current status
cancer therapy
combination therapy
adverse drug